Home > News > ABEC Inc. to Establish European HQ and Manufacturing Centre in Ireland
Industry Updates New Products Supplier News Upcoming Events business web

ABEC Inc. to Establish European HQ and Manufacturing Centre in Ireland

Hits:3785   Date: 2/4/2015
 
 
Pictured from left are County Cork Mayor Alan Coleman,
Minister of Jobs, Enterprise and Innovation Richard Bruton, VP, Commercial Operations Brady Cole, EVP, Service
Business Unit Dick Bonyun, CEO IDA Martin Shanahan,
and Minister of State Sean Sherlock, at the announcement
in Fermoy.
Bethlehem, PA USA – January 28, 2015

ABEC, Inc. today announced plans to expand its global operations in Fermoy, Co. Cork Ireland. The new operation will produce engineered process equipment for biopharmaceutical manufacturing and provide a range of service offerings to meet the growing demand from global pharmaceutical and biotech customers. The investment is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.

The company is to locate in an existing 87,000ft2 facility which occupies 13 acres of land on the edge of Fermoy town. Refurbishment works on the facility are underway, as well as recruitment for a
range of management, engineering, manufacturing, services, and business development personnel. The site will be a European center of excellence with complete engineering, design, manufacturing, process automation, testing, and field service capability.

Commenting on today’s announcement ABEC’s CEO Scott Pickering said: “This investment is a key component of ABEC’s broader strategy to deliver integrated process solutions on a global basis. The Fermoy facility will increase our capacity and allow us to better support our growing customer base in Ireland and Europe. We sincerely appreciate the support of the IDA as we establish our unique capabilities in Ireland.”

 
About ABEC Inc.

Since 1974, ABEC has been a leader in delivering integrated process solutions for manufacturing in the biopharmaceutical industry. Many of today’s leading antibody, vaccine, and recombinant protein therapies are manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC, and a majority of the world’s pharmaceutical and biotech companies are ABEC customers. ABEC’s unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether building new capacity or improving existing facilities, ABEC’s turn-key solutions reduce overall cost and time to market while delivering maximum productivity.
 
WWW.ABEC.COM